Agreements, Collaborations, and Partnerships are the Key Strategies Adopted by Leading Market Players to Foster Growth in the Global 3D Bioprinting Market
The global 3D bioprinting market was dominated by Organovo Holdings Inc. (U.S.) and EnvisionTEC GmbH (Germany) in 2015. Organovo Holdings Inc. held the leading position in the market in 2015, due to its robust 3D bioprinting portfolio. In addition, the co
(EMAILWIRE.COM, August 18, 2018 ) EnvisionTEC GmbH (Germany) held the second position in the 3D bioprinting market in 2015. The company has a strong 3D bioprinting product portfolio under its biofabrication range of products. The company primarily concentrates on developing innovative 3D bioprinting solutions to ensure its growth in the global market. The company also focuses on increasing its presence in Asian countries to leverage the high growth potential of this region. In February 2015, EnvisionTEC signed a distribution agreement with DiethelmKellerSiberHegner (DSKH), a Swiss-based market expansion services provider. This agreement enabled DSKH to market and distribute EnvisionTEC’s 3D bioprinting solutions in Malaysia, the Philippines, Singapore, Taiwan, and Vietnam.
Download FREE Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=170201787
In the 3D bioprinting market, leading players are adopting product launches, product development, partnerships, collaboration, and agreements to increase their market share. Market players adopted these strategies to gain access to new technologies, develop novel products, and expand their geographic presence & distribution networks. Leading players are also focusing on increasing their market visibility and strengthening their R&D capacities.
Nano3D Biosciences, Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), BioBots (U.S.), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (U.K.), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany) are other prominent companies in the 3D bioprinting market.
More Info: https://www.marketsandmarkets.com/Market-Reports/3d-bioprinting-market-170201787.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Media Contact
- Mr. Shelly Singh
- sales@marketsandmarkets.com